Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard(Institut Gustave Roussy), Benjamin Besse(Institut Gustave Roussy), Harry J.M. Groen(University Medical Center Groningen), Pierre-Jean Souquet(Hôpital Lyon Sud), Élisabeth Quoix(Hôpital Civil, Strasbourg), Christina S. Baik(University of Washington), Fabrice Barlési(Hôpital Nord), Tae Min Kim(Seoul National University Hospital), Julien Mazières(Hôpital Larrey), Silvia Novello(University of Turin), James R. Rigas(Dartmouth College), Allison Upalawanna(Novartis (Switzerland)), Anthony M. D’Amelio(Novartis (United States)), Pingkuan Zhang(Novartis (United States)), Bijoyesh Mookerjee(Novartis (United States)), Bruce E. Johnson(Dana-Farber Cancer Institute)
Cited by 874Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis